ea0070ep2 | Adrenal and Cardiovascular Endocrinology | ECE2020
Stępiński Kamil
, Jurecka-Lubieniecka Beata
, Michalik Barbara
, Gorki Karolina
, Jarząb Barbara
Introduction: Primary adrenocortical carcinoma (ACC) is a highly malignant but rare neoplasm. It can occur as a hormonally active or an inactive tumor. It is considered that about three-fourths of ACC cases are hormonally active, although they do not always give clinical symptoms. Mitotane (Lysodren) is registered by the FDA for the therapy of ACC, either for monotherapy or as a combined chemotherapy.Case report: A 34-year-old woman, with a histopatholog...